Table I.
Apoptosis-related proteins | SKM-1
|
KG1a
|
||||
---|---|---|---|---|---|---|
CUR/control (fold-change) | ATO/control (fold-change) | CUR+ATO/control (fold-change) | CUR/control (fold-change) | ATO/control (fold-change) | CUR+ATO/control (fold-change) | |
bad | 1.141 | 1.741 | 2.044a | 1.224 | 0.951 | 0.854 |
bax | 1.036 | 1.321 | 1.375 | 0.989 | 1.586 | 1.970a |
bcl-2 | 0.996 | 2.094 | 2.304a | 0.775 | 1.895 | 0.428b |
bcl-w | 1.083 | 1.892 | 2.098a | 0.852 | 1.907 | 0.667b |
BID | 0.739 | 0.272 | 0.543b | 0.934 | 1.254 | 1.138 |
BIM | 1.146 | 2.071 | 2.389a | 0.883 | 0.962 | 0.843 |
caspase3 | 1.172 | 2.280 | 2.616a | 1.125 | 1.967 | 2.812a |
caspase8 | 1.118 | 2.952 | 3.118a | 1.157 | 1.075 | 1.152 |
CD40 | 0.930 | 1.534 | 1.634a | 0.789 | 0.870 | 0.771 |
CD40L | 1.081 | 1.803 | 1.879a | 0.805 | 0.867 | 0.816 |
cIAP-2 | 0.934 | 0.491 | 0.528b | 0.664 | 1.320 | 0.345b |
cytoC | 1.011 | 2.156 | 2.918a | 1.314 | 1.916 | 2.848a |
DR6 | 1.063 | 1.448 | 1.588a | 0.792 | 0.924 | 0.822 |
Fas | 1.272 | 2.407 | 2.468a | 0.878 | 0.851 | 0.917 |
FasL | 1.080 | 1.601 | 1.694a | 0.841 | 1.026 | 0.858 |
HSP27 | 0.894 | 1.424 | 1.297 | 0.881 | 1.112 | 0.905 |
HSP60 | 1.084 | 1.604 | 1.721a | 0.858 | 0.972 | 0.899 |
HSP70 | 1.350 | 2.763 | 2.968a | 1.244 | 1.059 | 1.171 |
HTRA | 0.664 | 2.784 | 2.288a | 2.088 | 1.250 | 2.874a |
IGF-I | 0.891 | 1.187 | 1.163 | 0.794 | 1.068 | 0.720 |
IGF-II | 1.123 | 2.707 | 2.948a | 1.009 | 1.334 | 1.070 |
IGFBP-1 | 0.933 | 1.241 | 1.304 | 0.701 | 0.912 | 0.599b |
IGFBP-2 | 0.971 | 1.223 | 1.253 | 0.794 | 0.978 | 0.479b |
IGFBP-3 | 1.119 | 1.769 | 1.888a | 0.749 | 0.891 | 0.878 |
IGFBP-4 | 0.974 | 1.980 | 2.012a | 0.782 | 0.961 | 0.805 |
IGFBP-5 | 1.002 | 4.794 | 4.849a | 0.810 | 0.952 | 0.860 |
IGFBP-6 | 1.102 | 0.811 | 0.905 | 0.829 | 1.042 | 0.867 |
IGF-1sR | 0.929 | 1.320 | 1.340 | 0.745 | 0.965 | 0.880 |
livin | 1.139 | 43.971 | 47.444a | 0.913 | 1.102 | 0.910 |
p21 | 1.044 | 1.664 | 2.177a | 0.921 | 0.980 | 0.960 |
p27 | 1.200 | 2.269 | 2.624a | 0.918 | 1.057 | 0.950 |
p53 | 1.097 | 2.970 | 3.364a | 0.946 | 1.081 | 1.005 |
SMAC | 1.025 | 0.979 | 1.069 | 1.032 | 1.062 | 1.523a |
Survivin | 0.805 | 2.118 | 0.360b | 0.607 | 1.805 | 0.215b |
sTNF-R1 | 1.051 | 1.492 | 1.323 | 0.836 | 1.152 | 0.772 |
sTNF-R2 | 0.819 | 1.124 | 1.042 | 0.693 | 0.909 | 0.733 |
TNF-α | 0.828 | 1.263 | 1.393 | 0.671 | 1.012 | 0.723 |
TNF-β | 0.945 | 1.376 | 1.531a | 0.701 | 0.902 | 0.820 |
TRAILR-1 | 0.942 | 0.907 | 0.996 | 0.790 | 1.104 | 0.855 |
TRAILR-2 | 1.008 | 1.633 | 1.785a | 0.843 | 1.055 | 0.872 |
TRAILR-3 | 0.955 | 1.421 | 1.546a | 0.799 | 1.047 | 0.848 |
TRAILR-4 | 1.074 | 1.620 | 1.794a | 0.845 | 1.050 | 0.909 |
XIAP | 0.896 | 1.340 | 0.550b | 0.741 | 1.155 | 0.403b |
SKM-1 and KG1a cells were treated with CUR (10 μM) and ATO (8 μM) alone or in combination for 48 h, followed by detection using a protein array kit. Fold-changes ≤0.667 or ≥1.5 indicated proteins were modulated by these drugs.
Upregulated,
downregulated.